Table 6.
Postoperative outcomes at 90 days and 1 year in patients with HCV with 2-year mortality compared with those without after undergoing primary elective TJA
| Outcome | Mortality (n = 16) | No mortality (n = 153) | p value |
| 90-day complications | |||
| Dislocation | 0 (0) | 1 (2) | > 0.99 |
| Periprosthetic joint infection | 6 (1) | 4 (6) | 0.51 |
| Periprosthetic fracture | 0 (0) | 1 (1) | > 0.99 |
| Mechanical revision | 0 (0) | 3 (4) | > 0.99 |
| 1-year complications | |||
| Dislocation | 0 (0) | 1 (2) | > 0.99 |
| Periprosthetic joint infection | 6 (1) | 6 (9) | > 0.99 |
| Periprosthetic fracture | 0 (0) | 1 (2) | > 0.99 |
| Mechanical revision | 0 (0) | 7 (10) | 0.89 |
| Complications at any time | |||
| Periprosthetic joint infection | 6 (1) | 10 (15) | > 0.99 |
| Mechanical revision | 0 (0) | 11 (17) | 0.37 |
| Cellulitis or wound dehiscence | 0 (0) | 3 (4) | > 0.99 |
| Hematoma | 0 (0) | 3 (5) | > 0.99 |
Data presented as % (n) or mean ± SD.